While UK cystic fibrosis patients continue their long wait for access to Vertex’s Orkambi, the drug has received a label extension from the European Commission allowing it to be used in younger ...
The first-ever CRISPR-based gene-editing therapy has been approved for marketing in the UK for inherited blood disorders sickle cell disease (SCD) and transfusion-dependent beta thalassaemia (TDT), ...
Abstract: Graph neural networks (GNNs) witness impressive performances on homophilic graphs characterized by a higher number of edges connecting nodes of similar class labels. A decline in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback